Heart Disease Trial, Recruiting NCT06410690 Sponsor: Centro Cardiologico Monzino Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06410690
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have known or suspected coronary artery disease (a condition affecting the heart's blood vessels) and have been referred by their doctor for diagnostic testing
  • People whose heart scan (called a CCTA — a specialised CT scan of the heart) is performed using a modern, high-quality scanner (one with more than 64 slices)

Who may not be able to join:

  • People who have had any non-invasive heart diagnostic test in the 90 days before enrolling in the trial
  • People whose assessed risk of coronary artery disease is considered low-to-intermediate based on a specific medical scoring tool called the updated Diamond-Forrester model (confirm with trial site)
  • People who are currently experiencing an acute coronary syndrome (a sudden, serious heart event such as a heart attack or unstable chest pain)
  • People who are showing signs of being medically unstable at the time of enrolment
  • People who have a known allergy or other reason they cannot receive contrast dye, or who have reduced kidney function
  • People who are unable to hold their breath (which is required during the scan)
  • People who are pregnant
  • People who have irregular heart rhythms (cardiac arrhythmias)
  • People who have a pacemaker or an implantable heart device (such as a defibrillator)
  • People who have medical reasons preventing them from taking certain medications used during testing, including sublingual nitrates, beta-blockers, or adenosine
  • People who have a structural heart muscle disease (called structural cardiomyopathy)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0258002574

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centro Cardiologico Monzino
Registry
ClinicalTrials.gov
Start date
22 May 2023
Est. completion
30 November 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Creation of an automated integrative artificial intelligence (AI) approach for the stratification of CAD patients and assessment of vulnerable coronary plaques at risk of acute complications; Quantitative assessment of the atherosclerotic burden and high risk plaque features

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov